Related references
Note: Only part of the references are listed.Effect of lesogaberan, a novel GABAB-receptor agonist, on transient lower oesophageal sphincter relaxations in male subjects
G. E. Boeckxstaens et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Effects of Lesogaberan on Reflux and Lower Esophageal Sphincter Function in Patients With Gastroesophageal Reflux Disease
Guy E. Boeckxstaens et al.
GASTROENTEROLOGY (2010)
A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism
N. G. Hunfeld et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
(R)-(3-Amino-2-fluoropropyl) Phosphinic Acid (AZD3355), a Novel GABAB Receptor Agonist, Inhibits Transient Lower Esophageal Sphincter Relaxation through a Peripheral Mode of Action
Anders Lehmann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Stereoselective disposition of proton pump inhibitors
Tommy Andersson et al.
CLINICAL DRUG INVESTIGATION (2008)
Pharmacokinetic studies with esomeprazole, the (S)-isomer of omeprazole
T Andersson et al.
CLINICAL PHARMACOKINETICS (2001)
Share Paper
